These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp. Lumen AA; Li L; Li J; Ahmed Z; Meng Z; Owen A; Ellens H; Hidalgo IJ; Bentz J PLoS One; 2013; 8(8):e69394. PubMed ID: 23976943 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE. Tang F; Borchardt RT Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE. Tang F; Borchardt RT Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947 [TBL] [Abstract][Full Text] [Related]
5. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers. Zhang Y; Benet LZ Pharm Res; 1998 Oct; 15(10):1520-4. PubMed ID: 9794492 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model. Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473 [TBL] [Abstract][Full Text] [Related]
7. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Tang F; Horie K; Borchardt RT Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945 [TBL] [Abstract][Full Text] [Related]
8. Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism. Huang J; Si L; Jiang L; Fan Z; Qiu J; Li G Int J Pharm; 2008 May; 356(1-2):351-3. PubMed ID: 18242899 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946 [TBL] [Abstract][Full Text] [Related]
11. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Wu X; Whitfield LR; Stewart BH Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037 [TBL] [Abstract][Full Text] [Related]
12. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells. Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448 [TBL] [Abstract][Full Text] [Related]
13. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport. Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095 [TBL] [Abstract][Full Text] [Related]
14. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism. Kwatra D; Budda B; Vadlapudi AD; Vadlapatla RK; Pal D; Mitra AK Mol Pharm; 2012 Jul; 9(7):1877-86. PubMed ID: 22676443 [TBL] [Abstract][Full Text] [Related]
15. Transport characteristics of fexofenadine in the Caco-2 cell model. Petri N; Tannergren C; Rungstad D; Lennernäs H Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574 [TBL] [Abstract][Full Text] [Related]
16. Role of P-glycoprotein in the transport of tanshinone I, one active triterpenoid from Salvia miltiorrhiza. Li XX; Zhou ZW; Zhou SF Drug Metab Lett; 2008 Aug; 2(3):223-30. PubMed ID: 19356097 [TBL] [Abstract][Full Text] [Related]
17. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME; Podila L; Ely D; Almeida I Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365 [TBL] [Abstract][Full Text] [Related]
18. Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization. Jain R; Majumdar S; Nashed Y; Pal D; Mitra AK Mol Pharm; 2004; 1(4):290-9. PubMed ID: 15981588 [TBL] [Abstract][Full Text] [Related]
19. CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam. Cummins CL; Jacobsen W; Christians U; Benet LZ J Pharmacol Exp Ther; 2004 Jan; 308(1):143-55. PubMed ID: 14569063 [TBL] [Abstract][Full Text] [Related]
20. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. Profit L; Eagling VA; Back DJ AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]